breast cancer

Ibrance and Xtandi Could Be in the Top 10 Oncology Drugs by 2021
Market Realist
Mon, 08/29/16 - 04:16 pm
Ibrance
Xtandi
oncology
Pfizer
Medivation
breast cancer
prostate cancer
Drugmakers revive R&D focus on long stagnant women's health market
Medical Marketing and Media
Tue, 08/23/16 - 10:50 am
R&D
Women's Health
innovation
Myovant Sciences
Amgen
UCB Pharma
breast cancer
Pfizer
S1 Biopharma
Ibrance
Addyi
Lilly breast cancer drug stumbles, but trial continues
Yahoo/Reuters
Wed, 08/10/16 - 10:03 am
Eli Lilly
clinical trials
breast cancer
FDA
abemaciclib
fulvestrant
Novartis pill gets U.S. breakthrough designation in breast cancer
Yahoo/Reuters
Wed, 08/3/16 - 09:14 am
Novartis
breakthrough therapies
breast cancer
LEE011
Pfizer's Ibrance on pace for blockbuster status after strong Q2
BioPharma Dive
Wed, 08/3/16 - 09:00 am
Pfizer
Ibrance
breast cancer
Amgen and Allergan Study Finds Biosimilar Comparable to Herceptin
WSJ Online
Fri, 07/22/16 - 09:49 am
Amgen
Allergan
biosimilars
Herceptin
ABP 980
Roche
breast cancer
Puma Biotech shares jump on breast cancer study, FDA application
Marketwatch
Thu, 07/21/16 - 09:08 pm
Puma Biotechnology
FDA
breast cancer
neratinib
Galena Craters on Breast Cancer Vaccine Study Failure
TheStreet.com
Wed, 06/29/16 - 10:47 am
Galena Biopharma
NeuVax
breast cancer
vaccines
clinical trials
How Mylan Is Taking On One of the World's Top Breast Cancer Drugs
Fortune
Mon, 06/6/16 - 10:36 am
Roche
breast cancer
Herceptin
biosimilars
Mylan Labs
Breast cancer study shows benefit to extended treatment with aromatase inhibitors
Stat
Sun, 06/5/16 - 12:09 pm
breast cancer
ASCO 2016
aromatase inhibitors
Novartis
Femara
Pfizer
Five Storylines To Watch At ASCO
Forbes
Tue, 05/31/16 - 11:14 am
ASCO 2016
drug pricing
Pfizer
Ibrance
breast cancer
Tecentriq
Genentech
Roche
PDL-1 inhibitors
3 Stories To Watch At The Year’s Biggest Cancer Conference
Investors.com
Mon, 05/30/16 - 06:34 pm
ASCO 2016
Pfizer
Eli Lilly
breast cancer
Ibrance
abemaciclib
AbbVie
non-small cell lung cancer
Rova-T
Keytruda
Bristol-Myers Squibb
Merck
Opdivo
The mano-a-mano between Pfizer's Ibrance and Novartis' LEE011 nears with early PhIII wrap-up
Fierce Pharma
Wed, 05/18/16 - 04:27 pm
Pfizer
Ibrance
Novartis
LEE011
breast cancer
clinical trials
Pfizer Awards More Than $1 Million in Metastatic Breast Cancer Research Funding Through Breast Cancer: A Story Half Told Initiative
Yahoo
Wed, 05/11/16 - 10:50 am
Pfizer
R&D
breast cancer
metastatic breast cancer
3 Big Pharma Stocks With Credible Threats to Their Blockbusters
24/7 Wall St
Fri, 05/6/16 - 10:52 am
Pfizer
renal cancer
Sutent
cabozantinib
Exelixis
AstraZeneca
Faslodex
breast cancer
Atossa Genetics
Merck
Zetia
Mylan Labs
Pfizer Inc Cancer Drug Ibrance’s Prospects Boosted by Positive Phase 3 Data
Bidness, ETC
Wed, 04/20/16 - 12:40 pm
Pfizer
Ibrance
breast cancer
clinical trials
8 Major Biopharma Events Coming Later in 2016 and in 2017
24/7 Wall St
Tue, 03/29/16 - 10:33 pm
Vertex Pharmaceuticals
VX-661
cystic fibrosis
Incyte
ruxolitinib
colorectal cancer
breast cancer
Ultragenyx
KRN23
osteomalacia
GW Pharma
Epidiolex
Puma Biotechnology
neratinib
Celator Pharmaceuticals
Vyxeos
Biocryst
OPuS-2
BCX7353
HAE
Galena Biopharma
NeuVax
trastuzumab
Pfizer an Count on Ibrance for Upside and Massive Sales
Bidness, ETC
Mon, 02/22/16 - 09:33 am
Pfizer
Ibrance
breast cancer
advanced breast cancer
Pfizer keeps pushing on early hit Ibrance as Novartis, Lilly rivals near market
Fierce Pharma Marketing
Mon, 02/8/16 - 12:48 pm
Pfizer
Ibrance
breast cancer
Novartis
Eli Lilly
This little cancer drug didn’t make it to market
Stat
Sat, 01/9/16 - 10:44 am
Merrion
Orazol
bone cancer
breast cancer
FDA

Pages